Demonstration that certain rare cancer-related mutations can (i) be shared
by adjoining benign and cancerous tumor regions or (ii) be present solely i
n a cancerous but not in an adjoining benign tumor region are data often ci
ted in strong supportof the conventional idea that benign tumor regions con
sist of precancerous cells. However, considering the well-documented eviden
ce that many malignant cell types are still capable of regression through d
ifferentiation, one can envisage an alternative (or coincident) scenario wh
ereby (i) mutations are shared by adjoining benign and cancerous tumor regi
ons because a cancer cell with a non-differentiation;impairing mutation dif
ferentiates into a benign (postcancerous) cell or (ii) mutations are presen
t solely in a cancerous tumor region because a cancer cell acquires a diffe
rentiation-impairing mutation that prevents its regression into a benign ce
ll. Only with higher-resolution lineage analyses of a type not yet performe
d but experimentally feasible can these scenarios be distinguished. Accordi
ngly, it is quite possible that common cancers regularly differentiate, suc
h that a benign tumor region may actually harbor not only precancerous but
also postcancerous cells. Demonstration of this phenomenon and elucidation
of its mechanism could lead to novel therapeutics designed to effect revers
ion of the more common cancers that, when in advanced stages, are notorious
ly inadequately treated by current cytotoxic regimens. (C) 2000 Wiley-Liss,
Inc.